Paradigm Biopharmaceuticals Ltd.ASX: PAR

DSMB 20% Review Supports Phase 3, Moldova Activated

Apr 30, 2026 at 2:33 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd. has released a press release.

View Attachment